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INCIDENCE OF INTRA AND POSTOPERATIVE COMPLICATIONS 
ASSOCIATED WITH TRANSESOPHAGEAL ECHOCARDIOGRAMS (TEE) IN 
PEDIATRIC PATIENTS 
MICHAEL J. HALL 
ABSTRACT 
 
The benefits of intraoperative transesophageal echocardiography (TEE) 
during cardiac surgery are well documented.  Intraoperative TEE accurately 
confirms and in many cases refines delineation of congenital heart lesions, can 
be used as a means for establishing an intraoperative technical surgical score, 
and offers a low incidence of intraoperative complications.  It seemed likely that  
the rate of perioperative complications in children would be congruent with the 
current available data in adults. 
After Institutional Review Board approval, a retrospective chart review of 
patients at Boston Children’s Hospital who underwent the TEE procedure 
between May 2012 and December 2014 was conducted.  The final study sample 
consisted of 129 patient charts.  Adverse events related to TEE were 
documented and defined as follows: 1) those potentially attributable to TEE and 
2) those with a high likelihood of being related to TEE; defined as dysphagia, 
esophageal perforation, gastrointestinal bleeding, and throat discomfort/pain.   
Of the 129 total cases, there was only one case reporting an 
intraoperative adverse event with a high likelihood of being related to TEE.  This 
	  	   vi 
incidence rate of 0.77% is consistent with the literature existing on adult and 
pediatric TEE safety studies.  Literature on postoperative adverse events related 
to intraoperative TEE use in pediatric patients was limited to the incidence of 
dysphagia.  The sample included no incidence of dysphagia and the review 
enumerated six postoperative adverse events (4.65%) of which had a high 
likelihood of being related to TEE.  Three of these events were classified as 
major and three were classified as minor.  Major postoperative events included 
blood draining from nasogastric/orogastric tubes and blood tinged secretions 
suctioned from the endotracheal tube.  Minor events were patient reported as 
sore throat and voice hoarseness. 
It was concluded that TEE use is not associated with an increased risk of 
adverse events in pediatric patients if performed according to institutional 
procedure and recommendations.  Intraoperative TEE offers immediate 
assessment of the adequacy of surgical repair and presence of residual lesions.  
This information can be used to generate a surgical technical performance score.  
The ability to detect and correct residual lesions with information provided by 
intraoperative TEE allows the surgeon to improve technical performance thereby 
reducing postoperative morbidity. 
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INTRODUCTION 
 
Echocardiography 
Cardiac sonography was first described by Drs. Inge Edler and Carl Hertz 
in their paper, “The Use of Ultrasonic Reflectoscope for the Continuous 
Recording of the Movements of the Heart Walls,” first published in 1954.1  Since 
that time, such advancements have been made to allow for an ultrasound 
transducer probe to be placed within a patient’s esophagus in a procedure known 
as a transesophageal echocardiogram (TEE).2  TEE was first utilized in 1971 to 
record and measure blood flow through the aortic arch.2,3  In comparison to the 
standard transthoracic echocardiogram (TTE), it is generally considered that TEE 
offers a preferable imaging capability.4  TEE is typically done under general 
anesthesia with intubation as the probe must be placed into the patient’s 
esophagus.  Various probes exist with continuous wave Doppler, pulse wave 
Doppler, color Doppler, M-mode, 2-D, and 3-D echocardiography imaging 
capabilities.  Probes may possess one or more of the listed capabilities (see 
Table 1).4,5 
 
TEE Guidelines 
In 1992, the American Society of Echocardiography (ASE) and the Society 
of Cardiovascular Anesthesiologists (SCA) established their initial guidelines and 
recommendations for performing intraoperative transesophageal 
	  2 
echocardiography examination.6  In a 1999 follow-up report, a set of twenty views 
were defined in order to standardize the procedure.  The views were universal 
between an adult and pediatric examination.4,6  In 2013, the same organizations 
published updated guidelines and recommendations for TEE, which included an 
additional eight views.7  In addressing the original report:  
 
“Although the comprehensive intraoperative views have been widely 
adopted, they have a number of limitations. …  The 20 views do not 
address any specific diagnosis and do not include some views needed to 
adequately examine common cardiac disorders.”7 
 
The twenty-eight views are as described below in Figures 1 - 28. Letter 
designations with numerical subscript seen after “mitral valve” refer to specific 
leaflets of the valve.  Images were adapted from Table 10 of Hahn et al., 2013 
(see Appendix).7 
 
Figure 1: Five-Chamber View (ME) 
(Adapted from Hahn et al., 2013, Table 10) 
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As seen from the mid-esophageal level, the five-chamber view allows for 
visualization of the left atrium, right atrium, left ventricle, right ventricle, tricuspid 
valve, aortic valve, mitral valve (A2A1-P1), left ventricular outflow tract, and the 
interventricular septum.7 
 
Figure 2: Four-Chamber View 
(Adapted from Hahn et al., 2013, Table 10) 
 
As seen from the mid-esophageal level, the four-chamber view allows for 
visualization of the left atrium, right atrium, left ventricle, right ventricle, tricuspid 
valve, mitral valve (A3A2-P2P1), interventricular septum, and interatrial septum. 
Slight probe advancement allows for imaging of the coronary sinus.7 
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Figure 3: Mitral Commissural View 
(Adapted from Hahn et al., 2013, Table 10) 
 
As seen from the mid-esophageal level, the mitral commissural view allows for 
visualization of the left atrium, left ventricle, mitral valve (P3-A3A2A1-P1), coronary 
sinus, papillary muscles, and chordae tendinae.7 
 
Figure 4: Two-Chamber View (ME) 
(Adapted from Hahn et al., 2013, Table 10) 
 
As seen from the mid-esophageal level, the two-chamber view allows for 
visualization of the left atrium, left ventricle, left atrial appendage, mitral valve 
(P3-A3A2A1), and coronary sinus.7 
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Figure 5: Long Axis View 
(Adapted from Hahn et al., 2013, Table 10) 
 
As seen from the mid-esophageal level, the long axis view allows for visualization 
of the left atrium, left ventricle, aortic valve, mitral valve (P2-A2), left ventricular 
outflow tract, right ventricular outflow tract, coronary sinus, and the proximal 
ascending aorta.7 
 
Figure 6: Aortic Valve – Long Axis View 
(Adapted from Hahn et al., 2013, Table 10) 
 
As seen from the mid-esophageal level, the long axis view of the aortic valve 
allows for visualization of the left atrium, aortic valve, mitral valve (A2-P2), left 
ventricular outflow tract, right ventricular outflow tract, proximal ascending aorta, 
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sinuses of Valsalva, sinotubular junction, and a partial view of the ascending 
aorta.7 
 
Figure 7: Ascending Aorta – Long Axis View 
(Adapted from Hahn et al., 2013, Table 10) 
 
As seen from the mid-esophageal level, the long axis view of the ascending aorta 
allows for visualization of the proximal ascending aorta, mid-ascending aorta, 
right pulmonary artery, and pulmonary valve (with probe manipulation).7 
 
Figure 8: Ascending Aorta – Short Axis View 
(Adapted from Hahn et al., 2013, Table 10) 
 
As seen from the mid-esophageal level, the short axis view of the ascending 
aorta allows for visualization of the mid-ascending aorta, superior vena cava, 
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main pulmonary artery, the pulmonary artery bifurcation, and the right pulmonary 
artery . The pulmonary valve can sometimes be seen with this view.7 
 
Figure 9: Right Pulmonary Vein View 
(Adapted from Hahn et al., 2013, Table 10) 
 
As seen from the mid-esophageal level, the right pulmonary vein view allows for 
visualization of the mid-ascending aorta, superior vena cava, and the right 
pulmonary veins.7 
 
Figure 10: Aortic Valve – Short Axis View 
(Adapted from Hahn et al., 2013, Table 10) 
 
As seen from the mid-esophageal level, the short axis view of the aortic valve 
allows for visualization of the left atrium, right atrium, aortic valve, pulmonary 
valve, superior interatrial septum, and the right ventricular outflow tract.7 
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Figure 11: Right Ventricle Inflow-Outflow View (ME) 
(Adapted from Hahn et al., 2013, Table 10) 
 
As seen from the mid-esophageal level, the right ventricle inflow-outflow view 
allows for visualization of the left atrium, right atrium, aortic valve, tricuspid valve, 
pulmonary valve, superior interatrial septum, main pulmonary artery, and the 
right ventricular outflow tract.7 
 
Figure 12: Modified Bicaval Tricuspid Valve View 
(Adapted from Hahn et al., 2013, Table 10) 
 
As seen from the mid-esophageal level, the modified bicaval tricuspid valve view 
allows for visualization of the left atrium, right atrium, tricuspid valve, interatrial 
septum, superior vena cava, inferior vena cava, and the coronary sinus.7 
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Figure 13: Bicaval View 
(Adapted from Hahn et al., 2013, Table 10) 
 
As seen from the mid-esophageal level, the bicaval view allows for visualization 
of the left atrium, right atrium, right atrial appendage, superior vena cava, inferior 
vena cava, and the interatrial septum.7 
 
Figure 14: Right and Left Pulmonary Vein View 
(Adapted from Hahn et al., 2013, Table 10) 
 
 
As seen from the mid-esophageal level, the right and left pulmonary vein view 
allows for visualization of the pulmonary veins and the pulmonary artery.7 
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Figure 15: Left Atrial Appendage View 
(Adapted from Hahn et al., 2013, Table 10) 
 
As seen from the mid-esophageal level, the left atrial appendage view allows for 
visualization of the left atrial appendage and the left superior pulmonary vein 
(often).7 
 
Figure 16: Basal – Short Axis View 
(Adapted from Hahn et al., 2013, Table 10) 
 
As seen from the transgastric level, the short axis view of the basal portion of the 
heart allows for visualization of the left ventricle, right ventricle, and the mitral 
valve.7 
  
	  11 
 
Figure 17: Mid-Papillary – Short Axis View 
(Adapted from Hahn et al., 2013, Table 10) 
 
As seen from the transgastric level, the short axis view of the mid-papillary region 
allows for visualization of the left ventricle, right ventricle, and papillary muscles. 
Myocardium supplied by the left anterior descending coronary artery, circumflex 
coronary artery, and the right coronary artery are viewed simultaneously.7 
 
Figure 18: Apical – Short Axis View 
(Adapted from Hahn et al., 2013, Table 10) 
 
As seen from the transgastric level, the short axis view of the apex allows for 
visualization of the apexes of the left ventricle and right ventricle.7 
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Figure 19: Right Ventricle – Basal View 
(Adapted from Hahn et al., 2013, Table 10) 
 
As seen from the transgastric level, the view of the right ventricle allows for 
visualization of the left ventricle, right ventricle, tricuspid valve, pulmonary valve, 
and the right ventricular outflow tract.7 
 
Figure 20: Right Ventricle Inflow-Outflow View (TG) 
(Adapted from Hahn et al., 2013, Table 10) 
 
As seen from the transgastric level, the right ventricle inflow-outflow view allows 
for visualization of the right atrium, right ventricle, tricuspid valve, pulmonary 
valve, and the right ventricular outflow tract.7 
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Figure 21: Five-Chamber View (TG) 
(Adapted from Hahn et al., 2013, Table 10) 
 
As seen from the deep transgastric level, the five-chamber view allows for 
visualization of the left ventricle, right ventricle, aortic valve, mitral valve, left 
ventricular outflow tract, and the aortic root.7 
 
Figure 22: Two-Chamber View (TG) 
(Adapted from Hahn et al., 2013, Table 10) 
 
As seen from the transgastric level, the two-chamber view allows for visualization 
of the left atrium (often), left ventricle, mitral valve, left atrial appendage (often), 
papillary muscles, and the chordae tendinae.7 
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Figure 23: Right Ventricular Inflow View 
(Adapted from Hahn et al., 2013, Table 10) 
 
As seen from the transgastric level, the right ventricular inflow view allows for 
visualization of the right atrium, right ventricle, tricuspid valve, pulmonary valve 
(with probe manipulation), right ventricular outflow tract (often), papillary muscles, 
and the chordae tendinae.7 
 
Figure 24: Long Axis View (TG) 
(Adapted from Hahn et al., 2013, Table 10) 
 
As seen from the transgastric level, the long axis view allows for visualization of 
the left ventricle, right ventricle, aortic valve, mitral valve, left ventricular outflow 
tract, and the aortic root.7 
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Figure 25: Descending Aorta – Short Axis View 
(Adapted from Hahn et al., 2013, Table 10) 
 
Best seen from the level of the diaphragm and superior to the mid-esophageal 
level, the short axis view of the descending aorta allows for visualization of the 
descending aorta, hemiazygous vein, azygous vein, and intercostal arteries.  If 
the view is attempted at the transgastric level, the celiac artery may be 
visualized.7 
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Figure 26: Descending Aorta – Long Axis View 
(Adapted from Hahn et al., 2013, Table 10) 
 
Like the short axis view of the descending aorta, this view is best seen from the 
level of the diaphragm and superior to the mid-esophageal level with visualization 
of the descending aorta, hemiazygous vein, azygous vein, and intercostal 
arteries.7 
 
Figure 27: Aortic Arch – Long Axis View 
(Adapted from Hahn et al., 2013, Table 10) 
 
As seen from the upper esophageal level, the long axis view of the aortic arch 
allows for visualization of the aortic arch, left subclavian artery, innominate vein, 
and mediastinal tissue.7 
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Figure 28: Aortic Arch – Short Axis View 
(Adapted from Hahn et al., 2013, Table 10) 
 
As seen from the upper esophageal level, the short axis view of the aortic arch 
allows for visualization of the aortic arch, pulmonary valve, pulmonary artery, 
innominate vein, right brachiocephalic artery, left common carotid artery, and 
mediastinal tissue.7 
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TABLE 1 Types of Echocardiography4,5 
  
M-mode echocardiography M-mode echocardiography produces a one 
dimensional view of the structure in 
question displayed over a time axis. M-
mode is most useful in measuring the size 
of the various heart structures. 
Doppler echocardiography 
 
 
Doppler echocardiography is used to 
measure blood flow through individual 
structures of the heart. This technique is 
useful in evaluating valvular insufficiency, 
shunts, stenosis, and other flow related 
defects. 
Pulse Wave Doppler Pulse wave (PW) Doppler utilizes bursts of 
ultrasound to a specific distance from the 
transducer. PW Doppler allows for 
measurement of flow within a specific 
structure, but is limited in its ability to 
measure flow velocity by the rate of 
ultrasonic pulses. 
Continuous Wave Doppler Continuous wave (CW) Doppler utilizes a 
continuous transmission and reception of 
ultrasound. CW Doppler allows for 
unlimited measurement of flow velocity, 
but is limited in its ability to pinpoint a 
specific observation area. 
Color Doppler echocardiography Color Doppler is an enhanced form of PW 
Doppler. Color Doppler displays different 
colors to designate direction of flow 
(typically red represents flow towards the 
probe and blue represents flow way from 
the probe). 
Two-dimensional echocardiography 2-D echocardiography enables two 
dimensions of the heart to be visualized 
simultaneously (as opposed to one 
dimension in M-mode). This technique 
enables observation of the relative 
positioning between heart structures and 
the motion of heart structures. 
Three-dimensional echocardiography 3-D echocardiography provides enhanced 
anatomically realistic images of the heart 
structures over the 2-D echocardiogram.  
The third dimension allows for greater 
accuracy and assessment by the 
physician. 
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Congenital Heart Defects 
 In the normal adult, whole body circulation is achieved through the series, 
biventricular pumping of the heart to the pulmonary and systemic circulations.  
Systemically, oxygen deplete blood enters the right atrium from the inferior and 
superior vena cavas.  From the right atrium, blood passes through the tricuspid 
valve into the right ventricle.  The right ventricle pumps the deoxygenated blood 
into pulmonary circulation through the pulmonary valve into the pulmonary artery 
and onwards towards the lungs.  From the lungs, oxygen replete blood enters 
into the left atrium.  From the left atrium, the blood passes through the mitral 
valve into the left ventricle.  Finally, from the left ventricle the blood is pumped 
into systemic circulation through the aortic valve into the aorta.8 
 Fetal heart development is a dynamic process and development continues 
until just shortly after birth.  Noteworthy differences in neonatal heart anatomy 
include the existence of a hole between the right and left atria, known as a 
foramen ovale.  Additionally, there is the existence of a connection between the 
great arteries (aorta and pulmonary artery), known as the ductus arteriosus.8 
Congenital heart defects (CHDs) are defects in the heart that can alter 
normal blood circulation.  Manifested during fetal development, CHDs are 
present at birth and are the cause of congenital heart disease.8,9  According to 
the National Institute of Health (NIH) and the Center for Disease Control (CDC), 
CHDs are the most common type of birth defect affecting 8 per 1,000 births and 
approximately 40,000 births per year.8,9,10  Treatment of patients affected by CHD 
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varies according to severity and include medications, device insertion, surgical 
changes to anatomy, and/or heart transplant; the most severe of defects being 
classified as critical congenital heart defects (CCHDs).  Some CHD patients do 
not require treatment.  The more common defects are outlined below and in 
Table 2.8 
 
Atrial Septal Defect 
 An atrial septal defect (ASD) is a defect, or hole, in the wall of tissue 
separating the two atria of the heart.  This wall of tissue is known as the atrial 
septum.  As the child grows, this hole may begin to close on it’s own, but more 
severe defects require surgical intervention.  It is estimated that there are 
approximately 2,000 births per year in the United States with an ASD.  There are 
many potential complications associated with this defect and include: mixing of 
arterial and venous blood resulting in decreased oxygen saturation, pulmonary 
hypertension, heart failure, increased risk of stroke, lung infections, difficulty 
breathing, shortness of breath, peripheral edema, and pulmonary edema.8 
 
Atrioventricular Septal Defect 
 Similar to the ASD, the atrioventricular septal defect (AVSD) is 
characterized by a hole separating two or more of the heart chambers and can 
be classified as either a complete AVSD or a partial AVSD.  A complete AVSD 
exists when there is a large hole in the center of the heart where the atrial 
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septum and ventricular septum would ordinarily meet.  A complete AVSD also 
affects the normal flow of blood through the heart.  Due to the size of this defect 
instead of the typical anatomy of two internal heart valves, there exists one 
common valve in the center of the heart.8 
 A partial, or incomplete, AVSD is less severe compared to the complete 
AVSD.  The partial AVSD is characterized by a hole in the atrial septum with a 
small hole in the ventricular septum near where the two septa join.  Additionally, 
the partial AVSD heart typically will have the typical two valves between the 
respective atria and ventricles.8 
 As with the ASD, the complete and partial AVSDs have many of the same 
potential complications.  Of note, the degree to which there is arterial and venous 
blood mixing will generally be greater than with the ASD and will vary according 
to severity of the defect.  It is estimated that there are approximately 2,000 births 
per year in the United States with an AVSD.8 
 
Coarctation of the Aorta 
 Coarctation of the aorta is characterized by a narrowing of a part of the 
aorta.8,11  The defect typically occurs in proximal descending aorta near the 
ductus arteriosus, in the descending aorta.11  Like a stenotic aorta valve in the 
heart of an older individual, this narrowing increases the resistance of flow 
through the aorta.  This increased resistance to flow can cause an increase in the 
workload of the left ventricle.8,11  The result of this increased workload, if left 
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untreated, can cause thickening of the ventricular muscle and further cascade 
into heart failure resulting with its associated signs and symptoms.  Depending 
on the patient’s age upon presentation, clinical findings can range from heart 
failure to systemic hypertension in the upper extremities with diminished pulses 
in the lower extremities.  It is estimated that there are approximately 1,500 births 
per year in the United States with coarctation of the aorta.8 
 
Transposition of the Great Arteries 
Transposition of the great arteries (TGA) can refer to either dextro-
Transposition of the Great Arteries (d-TGA) or levo-Transposition of the Great 
Arteries (l-TGA).  TGA is strictly a switching of the position of the pulmonary 
artery and the aorta; the aorta connects the right ventricle and the pulmonary 
artery connects to the left ventricle.  Blood flow through a heart with d-TGA 
results in returning venous blood to the right atrium being immediately pumped 
systemically, bypassing the lungs.  Similarly, pulmonary venous return is 
immediately pumped back into pulmonary circulation.8 
This condition is not always fatal because it is almost always accompanied 
by a patent ductus arteriosus and either an ASD or ventricular septal defect 
(VSD), both of which allow for mixing of oxygenated and deoxygenated blood. 
Severity of symptoms is directly related to the degree of oxygenated and 
deoxygenated blood mixing.  It is estimated that there are approximately 1,250 
births per year in the United States with d-TGA and all require surgical 
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intervention.  The most common of surgical procedures to correct this defect is 
the arterial switch procedure.  As suggested by its name, this procedure 
relocates the transposed arteries to their normal anatomical locations.8 
L-TGA, also referred to as corrected TGA, is the condition in which, in 
addition to the transposition of the great arteries, the ventricles have also 
transposed; that is there is both ventriculoarterial and atrioventricular 
discordance.  In l-TGA, the right ventricle receives oxygenated blood from the left 
atria and pumps it systemically through the aorta.  Conversely, the left ventricle 
receives deoxygenated blood from the right atria and pumps it through the 
pulmonary artery.  This condition is extremely rare and is usually associated with 
the presence of a VSD, pulmonary stenosis and an abnormal tricuspid valve.8 
 
Hypoplastic Left Heart Syndrome 
 Hypoplastic Left Heart Syndrome (HLHS) is a CHD in which the left side of 
the heart does not develop properly.  Normal heart structures found in the left 
heart are either underdeveloped or nonexistent.  Anatomy of infants born with 
this syndrome is complex and so too are the procedures to correct the birth 
anatomy.  Generally, HLHS is characterized by an underdeveloped, 
nonfunctioning left ventricle.  Systemic circulation at birth is achieved as follows: 
oxygen rich blood returning to the left atria enters into the right atria via an ASD 
(or patent foramen ovale); mixed oxygenated and deoxygenated blood is then 
pumped to the pulmonary artery where it can be shunted to the aorta via the 
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patent ductus arteriosus.8  This single ventricle circulation is unsustainable and 
must begin to be addressed, almost immediately after birth, in a three-staged 
surgical palliation culminating in what is known as a Fontan circulation.8,12 
 It is estimated that there are approximately 960 births per year in the 
United States with HLHS.8 
 
Pulmonary Atresia 
 Pulmonary atresia is a condition in which no pulmonary valve forms.  As 
such, blood entering the right ventricle cannot pass into the pulmonary artery for 
transport through the pulmonary circulation.  This condition can present with or 
without a ventricular septal defect.  Any blood entering the right ventricle either 
regurgitates back into the right atria and then through a patent foramen ovale into 
the left atria; or, in the presence of a VSD, blood can additionally pass from the 
right ventricle into the left.  Blood in the left heart is pumped through the aorta 
with pulmonary circulation achieved through a patent ductus arteriosus.8 
 Treatment of pulmonary atresia varies according to severity of symptoms 
and size of the right ventricle.  Typically, treatment consists of surgery to open 
the tissue where the pulmonary valve should exist and implant a replacement 
valve.8  If the right ventricle is significantly underdeveloped, staged surgical 
palliation similar to the treatment of HLHS is performed.8,12  It is estimated that 
there are approximately 400 births per year in the United States with pulmonary 
atresia.8 
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Tetralogy of Fallot 
 Tetralogy of Fallot is a CHD and term that describes a defined group of 
heart defects occurring within the same patient.  The component defects are a 
VSD, positioning of the aorta over the VSD (over-riding aorta), right ventricular 
outflow tract obstruction due to a combination of  pulmonary valve stenosis, 
pulmonary artery stenosis, and infundibular obstruction (subpulmonic stenosis). 
Right ventricular hypertrophy develops as a consequence of chronic right 
ventricular outflow tract obstruction.  Like with most CHDs, these patients present 
clinically with decreased oxygen saturation and cyanosis.  Arterial and venous 
blood mixes at the site of the VSD and is circulated systemically through the 
aorta.8   
Surgical closure of the VSD and widening of the pulmonary valve and 
artery achieves sustainable heart function.  It may be necessary to repair or 
replace the pulmonary valve in a subsequent procedure for some patients.  It is 
estimated that there are approximately 1,700 births per year in the United States 
with Tetralogy of Fallot.8 
 
Anomalous Pulmonary Venous Return 
 Anomalous pulmonary venous return can be classified as either partial 
(PAPVR) or total (TAPVR).  In a normal heart, the pulmonary veins return 
oxygenated blood from the pulmonary circulation to the left atrium for continued 
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circulation systemically.  In PAPVR and TAPVR, all or some of the pulmonary 
veins return oxygenated blood back to the right atrium.  There are generally three 
subtypes of TAPVR: supracardiac, cardiac, and infracardiac; and are defined 
based upon the location of where the pulmonary veins connect.  In supracardiac 
TAPVR, the confluence of pulmonary veins drain via a vertical connecting vein to 
the superior vena cava and subsequently the right atrium.  In cardiac TAPVR, the 
confluence of pulmonary veins drain directly into the right atria usually via the 
coronary sinus. In infracardiac TAPVR, the confluence of pulmonary veins drain 
via a connecting vein to a venous structure below the diaphragm (usually a 
hepatic vein or the inferior vena cava which then returns to the right atria.  It is 
estimated that there are approximately 400 combined births per year in the 
United States with PAPVR or TAPVR.8 
 
Tricuspid Atresia 
 In the normal heart, blood from the right atrium passes through the 
tricuspid valve as it enters into the right ventricle.  With tricuspid atresia the TV 
does not form at all.  Infants with tricuspid atresia always have other defects such 
as, an ASD, VSD, patent foramen ovale, and/or patent ductus arteriosus.  These 
defects will allow for mixing of oxygenated and deoxygenated blood and delivery 
of blood to the pulmonary circulation.8  Treatment for tricuspid atresia includes 
staged surgical procedures to establish a Fontan circulation. In the initial period 
following birth use of medication to maintain ductal patency may be necessary to 
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to allow for oxygenated and deoxygenated blood mixing, interim to surgical 
interventions.8,12  It is estimated that there are approximately 400 births per year 
in the United States with tricuspid atresia.8 
 
Ventricular Septal Defect 
 A ventricular septal defect (VSD) is hole that exists in the tissue 
separating the two ventricles.  The structure of the septum varies significantly 
and defects in different regions of the septum have specific names.  A VSD 
allows for mixing of oxygenated and deoxygenated blood within the heart.  
Typically, blood from the left ventricle will flow into the right ventricle.  This flow 
across the ventricles will cause increased blood volume to the lungs resulting in 
pulmonary hypertension, impaired gas exchange across the pulmonary capillary 
bed, and increased work of breathing, among other complications.  As the child 
grows, the defect may begin to close on it’s own, but more severe defects require 
surgical intervention.  It is estimated that there are approximately 16,500 births 
per year in the United States with a VSD.8  
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TABLE 2 Types of Congenital Heart Defects8,9  
  
Atrial Septal Defect (ASD) A hole in the septum dividing the atria 
Atrioventricular Septal Defect (AVSD) A large hole in the center of the heart 
where the atrial septum and ventricular 
septum would normally meet 
Coarctication of the Aorta A narrowing of the aorta near the ductus 
arteriosus 
Transposition of the Great Arteries 
(TGA) 
A switching of the positions of the 
pulmonary artery and aorta 
Hypoplastic Left Heart Syndrome 
(HLHS) 
The left atrium and ventricle is 
underdeveloped and generally 
nonfunctioning 
Pulmonary Atresia No formation of the pulmonary valve 
Tetralogy of Fallot A stenotic pulmonary valve and artery, an 
enlarged aorta, VSD, and right ventricular 
hypertrophy 
Anomalous Pulmonary Venous Return All or some of the pulmonary veins return 
blood to the right atrium 
Tricuspid Atresia No formation of the tricuspid valve 
Ventricular Septal Defect (VSD) A hole in the septum dividing the 
ventricles 
 
Clinical Review 
Prior to echocardiography, the primary method for diagnosis of simple and 
complex congenital heart defects was cardiac catheterization.13  After the 
introduction of echocardiography, it was commonly accepted as a first-line 
imagining modality, but controversy existed in the field over the necessity of 
cardiac catheterization to confirm diagnosis.  In 1998, Tworetzky et al, sought to 
resolve this controversy undertaking a retrospective study to “determine the 
diagnostic accuracy of echocardiography alone.”13  Their results suggested that 
“echocardiography alone is an accurate tool for the preoperative diagnosis of 
major congenital heart defects in most children undergoing primary complete 
repair, and may obviate the need for routine diagnostic catheterization.”13 
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At Boston Children’s Hospital in 2006, Larrazabal et al were able to utilize 
a host of echocardiographic data to establish a means to technically assess and 
score surgical performance across a diverse array of congenital heart defect 
procedures.14 
Again at Boston Children’s Hospital, in 2011, Nathan et al demonstrated 
that the previously created technical performance score was indeed an accurate 
predictor of patient outcomes and postoperative morbidity.10,15  Furthermore, it 
was shown that postoperative morbidity was not affected by intraoperative 
surgical revision.16  There was no significant difference in patient outcomes 
between cases where no reintervention was required and those cases that 
underwent immediate intraoperative reintervention, provided that the technical 
scores at the end of the case were satisfactory.16,17  Comparatively, those 
patients who underwent postoperative surgical or catheter reintervention had 
significantly longer ICU lengths of stay over both the no reintervention required 
and the intraoperative reintervention groups (p < 0.0001 and p < 0.005, 
respectively).16  These findings have been supported in subsequent studies.17,18 
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It can be inferred from Figure 29, and subsequently confirmed by a follow-
up study by Nathan et al in 2014, that achieving an optimal surgical repair, 
without need for postoperative reintervention, results in shorter postoperative 
length of stay and a lower likelihood of postoperative adverse events in patients 
following congenital heart surgery.  In the same study, it was additionally 
determined that in order to reduce the need for postoperative reintervention, the 
identification of residual lesions intraoperatively is critical.16,17 
The benefits of intraoperative transesophageal echocardiography (TEE) 
during cardiac surgery are well documented.2,4,16,17,19,20,21  Intraoperative TEE 
Po
st
op
	  IC
U
	  L
en
gt
h	  
of
	  
St
ay
	  
Figure 29: Length of Stay Analysis 
(Adapted from Nathan et al., 2011.)   
 
Subgroup analysis of intensive care unit length of 
stay in patients requiring no reintervention 
compared to intraoperative reintervention; no 
reintervention to postoperative reintervention; and 
intraoperative reintervention to postoperative 
reintervention.16 
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accurately confirms and in many cases refines delineation of congenital heart 
lesions,13 can be used as a means for establishing an intraoperative technical 
surgical score,14,16 and offers a low incidence of intraoperative complications.21  It 
was hypothesized that the rate of perioperative complications in children would 
be congruent with the current available data in adults.  As a secondary aim the 
study sought to assess the overall compliance with established practices for 
probe size selection and placement at Boston Children’s Hospital. 
Intraoperative transesophageal echocardiograms offer an immediate 
feedback and technical performance score to the surgeon.4  Having the ability to 
improve technical performance scores intraoperatively definitively offers the 
opportunity for lower postoperative morbidity.16 
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METHODS 
 
After Institutional Review Board submission and approval, a retrospective 
chart review of patients at Boston Children’s Hospital who underwent the TEE 
procedure between May 2012 and December 2014 was conducted.  Exclusion 
criteria included age greater than 18 years at the time of procedure and TEE 
examinations associated with complex operative procedures, following which 
elective tracheal extubation within 24 hours after completion of surgery was not 
anticipated.  This criterion was set as a benchmark in order to reduce 
confounding variables in our determination of the likelihood that an adverse event 
was truly a result of TEE.  As a result, the majority of patients who were included 
in the study had undergone either a pulmonary valve replacement (PVR) or atrial 
septal defect (ASD) closure.  PVR and ASD cases with additional procedures 
performed at time of the TEE procedure were evaluated on their study eligibility 
on an individual basis.  The final study sample consisted of 129 patient charts.  
Adverse events related to TEE were documented and defined as follows: 1) 
those potentially attributable to TEE and 2) those with a high likelihood of being 
related to TEE; defined as dysphagia, esophageal perforation, gastrointestinal 
bleeding, and throat discomfort/pain.22,23  Incidence rates were calculated at the 
aforementioned incidence levels of adverse events and compared against 
previous study data as population comparison.20,21,22 
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Patient charts were reviewed from the day of surgery through their time in 
the intensive care unit (ICU); exception protocol to be outlined.  For purposes of 
recording a patient transferred from the ICU to the ward on the day of surgery 
was documented as spending 0 days in the unit.  If the same patient was 
transferred from the ICU to the ward at 00:00 (postop day 1), they would be 
documented as spending 1 day in the unit.  
At the onset of the study, the investigation team did not identify or foresee 
any potential health risks or discomforts to our patients, as the study was to be a 
retrospective chart review.  Patients did not experience additional procedures 
beyond what was required for clinical care purposes.  All electronic health data 
was and is stored in a password protected study folder accessible only to the 
investigatory team.  Remote access to data was achieved through established 
institutional encryption requirements.  All of the study personnel were and are 
familiar with HIPAA guidelines prior to accessing patient data.  The data collected 
that is protected by HIPAA was the minimum required for finding potential 
subjects for this study.  No additional protected health information was collected.  
Once a patient was determined to be eligible for full study investigation, the 
additional data collected was strictly related to diagnosis information and 
perioperative findings. Furthermore, the identities of patients in the study were 
only seen by the data collectors and by no other person.   
Perioperative findings were investigated and documented from onset of 
anesthetic induction to transfer from intensive care unit to the general ward; or 
	  34 
according to the exception protocol.  By formally analyzing the incidence of 
adverse events associated with TEE and compliance with Boston Children’s 
Hospital internally developed TEE procedure form completion, we may be able to 
improve health outcomes of patients requiring TEE. 
 
Exception Protocol 
 Exceptions to the above protocol of reviewing patient charts through the 
duration of intensive care unit stay were made for those patients who were 
admitted directly from the operating room to the general ward.  For these 
patients, charts were reviewed from onset of anesthetic induction to their 
discharge from the hospital.  These patients were included in this study as they 
were considered among the least complex of surgical cases and were not 
expected to add any confounding to our observations of adverse events.  There 
were 13 patient charts out of the 129 that were reviewed in this fashion.  This 
protocol does not apply to those patients designated as spending 0 days in the 
ICU. 
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RESULTS 
 
For the patients that spent time in the ICU, the mean number of days until 
transfer to the ward was 1.43.  This number included one outlier patient that 
spent 27 days in the ICU.  Without this outlier, the mean time spent in the ICU 
dropped to 1.21 days.  There was one patient that expired in the ICU and was 
not included in this mean calculation.  The mean number of days until discharge 
for the 13 patients reviewed under the exception protocol was 1.23.   
The age distribution of the study sample is shown below in Figure 30.  As 
expected, the distribution is not normal.  The age of patients who undergo 
surgical repair of CHDs and follow-up palliation is greatly influenced by a vast 
continuum of factors. 
  
Figure 30: Age distribution of included patients. Mean: 7.93 years. 
 
0	  2	  
4	  6	  
8	  10	  
12	  14	  
16	  18	  
0	   1	   2	   3	   4	   5	   6	   7	   8	   9	   10	  11	  12	  13	  14	  15	  16	  17	  
Fr
eq
ue
nc
y	  
Age	  (Years)	  
Age	  Frequency	  
	  
	  36 
Types of Adverse Events 
 Upon completion of analysis of patient charts, the adverse events noted 
were sorted into categories as seen in Figures 31 and 32.  Airway events were 
defined as complications occurring in the oral cavity, nasopharynx, and the 
oropharynx extending inferiorly to the larynx.  Specific types of events included 
and noted to have occurred were stridor, upper airway congestion, upper airway 
obstruction, secretions, and sore throat.  In intubated patients, endotracheal 
secretions were also included as an airway event.  Respiratory events were 
defined as complications occurring mainly within the lungs.  Specific events 
included occurrences of pneumothorax, pulmonary edema, desaturation, and 
lung collapse.  Cardiac events were defined as noted arrhythmias.  Thoracic 
events were defined by events such as chest pain, without any notation 
regarding arrhythmia.  Gastrointestinal events were adverse events occurring 
between the esophagus and the bowels.  These events included any noted 
bleeding or discomfort.  Nausea and emesis were never marked as adverse 
events as these are known complications associated with anesthesia.  There was 
one neurological event that consisted of seizure activity.  All of the adverse 
events are seen below in Figure 31. 
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Figure 31: All adverse events categorized by type. 
  
After further analysis of adverse events, we were able to rule out some 
events based on their likelihood of being attributable to other variables, such as 
arrhythmias and complications that could be attributed to comorbidities.  For 
example, individuals with Trisomy 21 (Down Syndrome), Noonan Syndrome, and 
VACTERL Syndrome are all predisposed to having airway obstructions and were 
therefore counted as confounding variables.24  The neurological event was 
considered to potentially be related to TEE because we were unable to 
specifically attribute it to any other cause.  The cardiac event was documented as 
an arrhythmia intraoperatively and was considered attributable to TEE because it 
was specifically noted to have occurred during the TEE procedure.  Other 
arrhythmias were attributed to the nature of the patient population and are to be 
expected, especially following heart surgery.  Thoracic events such as chest pain 
were attributed to incision pain following surgery.  Figure 32 displays the results. 
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Figure 32: Adverse events potentially attributable to TEE. 
19 cases with 22 complications.  1473 per 10,000. 
 
Of the 129 total cases, there was only one case reporting an 
intraoperative adverse event with a high likelihood of being related to TEE.  This 
incidence rate of 0.77% (77 per 10,000) is consistent with the literature existing 
on adult and pediatric TEE safety studies.21  Literature on postoperative adverse 
events related to intraoperative TEE use in pediatric patients was limited to the 
incidence of dysphagia.25  The sample included no instance of dysphagia.  Our 
review enumerated six postoperative adverse events (4.65%, 465 per 10,000) of 
which had a high likelihood of being related to TEE.  Three of these events were 
classified as major and three were classified as minor.  Major postoperative 
events included blood draining from nasogastric/orogastric tubes and blood 
tinged secretions suctioned from the endotracheal tube.  Minor events were 
patient reported as sore throat and voice hoarseness. 
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DISCUSSION 
 
 As noted in the results, there was one patient that spent 27 days in the 
ICU and there was one patient that expired.  These patients, henceforth referred 
to as Patients A and B respectively, are represented in Figure 31, but were not 
included in further incidence rates.   
 
A brief highlight of hospital course for Patients A and B: 
 
Patient A was admitted to the operating theatre for closure of an ASD and 
possible repair of the mitral valve.  Intraoperatively, repair of a prolapsed mitral 
valve was deemed necessary.  Over the course of the operation, the patient 
experienced an arrhythmia (ST elevation).  Intraoperative TEE examination 
observed poor biventricular systolic function.  Postoperatively this patient 
experienced multiple arrhythmias, including atrial flutter, ventricular tachycardia, 
and a ventricular fibrillation arrest requiring cardiopulmonary resuscitation.  One 
day postop the patient was placed on extracorporeal membrane oxygenation 
(ECMO).  Catheterization lab examination after transfer to ECMO demonstrated 
poor right ventricle function.  As noted in the introduction, the mitral valve exists 
and is the passage point between the right atrium and right ventricle.  The patient 
recovered from this course; ECMO was discontinued after 7 days and the patient 
was transferred to the ward after 27 days. 
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 Patient B underwent a TEE examination in the catheterization lab for 
assessment of chronic heart failure approximately 18 months status post heart 
transplant.  A left ventricular assist device (LVAD) had been implanted 
approximately five months post transplant.  The patient had been intubated, 
characterized as being in critical condition, and was being cared for in the ICU 
prior to this examination.  It was decided to terminate artificial ventilations and the 
LVAD three days after the TEE examination.  To that end, the patient ultimately 
expired. 
Amongst the research team, it is consensus that although Patients A and 
B qualified for the study based upon the inclusion parameters, their challenging 
hospital course was due to the risks surrounding surgical intervention (Patient A) 
and the risks accompanying the specific medical history (Patient B). 
In future studies, it would be recommended to include a broader 
diagnostic range of patients.  This study was limited in that there was no control 
group to compare our treatment sample against.  This limitation existed because 
of the preexistence of an institutional policy, whereby every patient undergoing 
surgical palliation for CHD undergoes intraoperative TEE.  This practice was 
established prior to the onset of this safety study because it was commonly 
perceived in the clinic that there was little risk of major complications associated 
with TEE.  This study was designed to formally submit to the academic medical 
community that which was generally understood to be true and safe by the 
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clinicians.  Boston Children’s Hospital is one of the pioneers in pediatric TEE use 
and employs the experts in the clinical use of pediatric TEE. 
 
Conclusion 
It can be concluded  that TEE use is not associated with an increased risk 
of adverse events in pediatric patients if performed according to institutional 
procedure and recommendations.  Intraoperative TEE offers immediate 
assessment of the adequacy of surgical repair and presence of residual lesions.  
This information can be used to generate a surgical technical performance score.  
The ability to detect and correct residual lesions with information provided by 
intraoperative TEE allows the surgeon to improve technical performance thereby 
reducing postoperative morbidity.  
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APPENDIX 
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Table 10, Hahn et al., 20137 
  
	  44 
REFERENCES 	  
1. Edler I, & Hertz CH.  The use of ultrasonic reflectoscope for the continuous recording of 
the movements of heart walls. 1954. Clinical Physiology and Functional Imaging.  
2004;24:118–136. 
 
2. Frazin L, Talano JV, Stephanides L, Loeb HS, Kopel L, & Gunnar RM.  Esophageal 
echocardiography. Circulation.  1976;54:102–108. 
 
3. Feigenbaum H.  Evolution of echocardiography. Circulation.  2006;93:1321–1327. 
 
4. Sundar S, & DiNardo JA.  Transesophageal echocardiography in pediatric surgery. 
International Anesthesiology Clinics.  2008;46:137–155.  
 
5. Johns Hopkins Medicine.  Transesophageal Echocardiogram.  Available at 
http://www.hopkinsmedicine.org/healthlibrary/test_procedures/cardiovascular/transesoph
ageal_echocardiogram_92,P07986.  Accessed March 4, 2015. 
 
6. Ayres NA, Miller-Hance W, Fyfe DA, Stevenson JG, Sahn DJ, Young LT, et al.  
Indications and guidelines for performance of transesophageal echocardiography in the 
patient with pediatric acquired or congenital heart disease. Journal of the American 
Society of Echocardiography.  2005;18:91–98. 
 
7. Hahn RT, Abraham T, Adams MS, Bruce CJ, Glas KE, Lang RM, et al.  Guidelines for 
Performing a Comprehensive Transesophageal Echocardiographic Examination: 
Recommendations from the American Society of Echocardiography and the Society of 
Cardiovascular Anesthesiologists. Journal of the American Society of Echocardiography.  
2013;26:921–964. 
 
8. Center for Disease Control.  Congenital heart defects.  Available at 
http://www.cdc.gov/ncbddd/heartdefects/index.html.  Accessed March 4, 2015. 
 
9. National Heart, Lung, and Blood Institute.  Congenital heart defects.  Available at 
http://www.nhlbi.nih.gov/health/health-topics/topics/chd.  Accessed March 4, 2015. 
 
10. Nathan M, Pigula FA, Liu H, Gauvreau K, Colan SD, Fynn-Thompson F., et al.  
Inadequate Technical Performance Scores Are Associated With Late Mortality and Late 
Reintervention. The Annals of Thoracic Surgery.  2013;96:664–669. 
 
11. Oh J, Seward J, & Tajik AJ.  Obstruction to Blood Flow: Coarctation of the Aorta. In The 
Echo Manual (2007;3rd ed., pp. 349–352). Lippincott Williams & Wilkins. 
 
12. Delmo Walter EMB, Hübler M, Alexi-Meskishvili V, Miera O, Weng Y, Loforte A, et al.  
Staged Surgical Palliation in Hypoplastic Left Heart Syndrome and Its Variants. Journal of 
Cardiac Surgery.  2009;244:383–391. 
 
13. Tworetzky W, McElhinney DB, Brook MM, Reddy VM, Hanley FL, & Silverman NH.  
Echocardiographic diagnosis alone for the complete repair of major congenital heart 
defects. Journal of the American College of Cardiology.  1999;33:228–233. 
 
 
	  45 
 
14. Larrazabal LA, del Nido PJ, Jenkins KJ, Gauvreau K, Lacro R, Colan SD, et al.  
Measurement of technical performance in congenital heart surgery: a pilot study. The 
Annals of Thoracic Surgery.  2007;83:179–184.  
 
15. Nathan M, Karamichalis JM, Liu H, Emani S, Baird C, Pigula F, et al.  Surgical technical 
performance scores are predictors of late mortality and unplanned reinterventions in 
infants after cardiac surgery. The Journal of Thoracic and Cardiovascular Surgery.  
2012;144:1095–1101.e7. 
 
16. Nathan M, Karamichalis JM, Liu H, del Nido P, Pigula F, Thiagarajan R, & Bacha EA.  
Intraoperative adverse events can be compensated by technical performance in 
neonates and infants after cardiac surgery: A prospective study. The Journal of Thoracic 
and Cardiovascular Surgery.  2011;142:1098–1107.e5. 
 
17. Nathan M, Gauvreau K, Liu H, Pigula FA, Mayer JE, Colan SD, & del Nido PJ.  
Outcomes differ in patients who undergo immediate intraoperative revision versus 
patients with delayed postoperative revision of residual lesions in congenital heart 
operations. The Journal of Thoracic and Cardiovascular Surgery.  2014;148:2540–
2547.e5.  
 
18. Nathan M, Karamichalis J, Liu H, Gauvreau K, Colan S, Saia M, et al.  Technical 
Performance Scores are strongly associated with early mortality, postoperative adverse 
events, and intensive care unit length of stay—analysis of consecutive discharges for 2 
years. The Journal of Thoracic and Cardiovascular Surgery.  2014;147:389–396.e3. 
 
19. Rosenfeld HM, Gentles TL, Wernovsky G, Laussen PC, Jonas RA, Mayer JE, et al.  
Utility of intraoperative transesophageal echocardiography in the assessment of residual 
cardiac defects. Pediatric Cardiology.  1998;19:346–351. 
 
20. Randolph GR, Hagler DJ, Connolly HM, Dearani JA, Puga FJ, Danielson GK, et al.  
Intraoperative transesophageal echocardiography during surgery for congenital heart 
defects. The Journal of Thoracic and Cardiovascular Surgery.  2002;124:1176–1182. 
 
21. Hilberath JN, Oakes DA, Shernan SK, Bulwer BE, D’Ambra MN, & Eltzschig HK.  Safety 
of Transesophageal Echocardiography. Journal of the American Society of 
Echocardiography.  2010;23:1115–1127.  
 
22. Stevenson JG.  Incidence of complications in pediatric transesophageal 
echocardiography: experience in 1650 cases. Journal of the American Society of 
Echocardiography: Official Publication of the American Society of Echocardiography.  
1999;12:527–532. 
 
23. Hogue CW, Lappas GD, Creswell LL, Ferguson TB, Sample M, Pugh D, et al.  
Swallowing dysfunction after cardiac operations: associated adverse outcomes and risk 
factors including intraoperative transesophageal echocardiography. The Journal of 
Thoracic and Cardiovascular Surgery.  1995;110:517–522. 
 
24. Formigari R, Michielon G, Digilio MC, Piacentini G, Carotti A, Giardini A, et al.  Genetic 
syndromes and congenital heart defects: how is surgical management affected? 
European Journal of Cardio-Thoracic Surgery.  2009;35:606–614. 
 
 
	  46 
 
25. Kohr LM, Dargan M, Hague A, Nelson SP, Duffy E, Backer CL, & Mavroudis C.  The 
incidence of dysphagia in pediatric patients after open heart procedures with 
transesophageal echocardiography. The Annals of Thoracic Surgery.  2003;76:1450–
1456.	    
	  47 
CURRICULUM VITAE 
MICHAEL J. HALL 
BIRTH: 1989 
 
Permanent Address: 
 32 Holden Street 
 Attleboro, MA 02703 
Current Address: 
 524 Harvard Street, Apt. 1 
 Brookline, MA 02446 
 
+1 774 254 6399 
mhallj@bu.edu 
hall.michael@alumni.neu.edu 
 
 
EDUCATION:  
  
University of Vermont 
Candidate for the degree of Doctor of Medicine 
Burlington, VT 
May 2019 
  
Boston University 
Candidate for the degree of Master of Science in Medical Sciences 
Boston, MA 
May 2015 
  
Northeastern University 
Bachelor of Science in Biology, Minor in Psychology, cum laude 
Boston, MA 
August 2011 
  
  
CERTIFICATIONS:  
  
American Heart Association 
Basic Life Support Instructor 
ID #: 12140294191 
 
Basic Life Support CPR for Healthcare Providers 
 
 
Quincy, MA 
December 2014 
 
Taunton, MA 
July 2009 
  
Commonwealth of Massachusetts 
Emergency Medical Technician – Basic 
Cert #: E884771 
 
Taunton, MA 
February 2010 
 
 
 
 
	  48 
EXPERIENCE: 
  
Boston Children’s Hospital 
Department of Anesthesia, Perioperative and Pain Medicine 
Division of Perioperative Medicine 
Anesthesia Technician 
• Stocking of medications for anesthesia carts 
• Anesthesia machine cleaning and airway setup for operating 
room cases 
 
Division of Cardiac Anesthesia 
Graduate Research Assistant 
• IRB development, data collection, analysis, and manuscript 
production for safety study of transesophageal echocardiograms 
Boston, MA 
 
 
Nov 2014 – Present 
 
 
 
 
 
Jul 2014 – Present 
  
Fallon Ambulance Service 
Department of Training and Education 
BLS Training Assistant 
• Course development, implementation, instruction, and 
evaluation for internal company, state, and national training 
protocols and standards of trainees and continuing education 
 
Department of Operations 
Emergency Medical Technician – Basic 
• Emergent and non-emergent medical transport of patients 
• Providing appropriate pre-hospital medical care within the scope 
of Massachusetts Statewide Treatment Protocols with adherence 
to company standards and policies 
Quincy, MA 
 
Dec 2014 – Present 
 
 
 
 
 
 
Jun 2011 – Present 
  
Sturdy Memorial Hospital 
Department of Emergency Services 
Emergency Technician 
• Providing nursing support: vital signs, wound/trauma care, CPR, 
toileting, patient transport with associated appropriate electronic 
medical record documentation 
• Assisting physicians in various sterile procedures 
Attleboro, MA 
 
Feb 2012 – Aug 2013 
  
Northeastern University 
Marine Science Center 
Department of Biology 
Undergraduate Research Assistant 
• Data collection, analysis, and manuscript production of 
embryological/ecological mammal study 
Nahant, MA 
 
 
Jan 2011 – Mar 2012 
  
 
 
 
 
 
 
	  49 
Genesis HealthCare 
Genesis Rehabilitation Services 
Rehabilitation Technician 
• Assisting occupational and physical therapists in treatment of 
patients 
• Conducting maintenance therapy programs 
• Toileting/hygiene of dependent patients, functional transfers, 
reporting/monitoring vitals 
Brookline, MA 
 
Jan – Jun 2010 
 
